In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, we are pleased to announce herewith that the...
23 Feb, 2026 | 10:24am • Source: NSE
In accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are please to announce herewith about commencement of operation...
23 Feb, 2026 | 09:49am • Source: BSE
In accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herewith intimate about ESG rating of the Company, as...
20 Feb, 2026 | 05:35pm • Source: BSE
In accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herewith intimate about allotment of 11,778 shares as per...
18 Feb, 2026 | 11:13am • Source: BSE
IPCA Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
16 Feb, 2026 | 11:46am • Source: NSE
In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time, we hereby submit the...
16 Feb, 2026 | 11:18am • Source: BSE
In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Transcript of the Earning Conference Call scheduled on Tuesday,...
10 Feb, 2026 | 12:40pm • Source:
In accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Transcript of the Earning Call, held...
10 Feb, 2026 | 12:07pm • Source: BSE
In accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herewith intimate about allotment of shares under ESOP granted,...
10 Feb, 2026 | 12:05pm • Source: BSE
In accordance with Reg. 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Reg. 41(4) of the SEBI (Issue of Capital and...
04 Feb, 2026 | 02:52pm • Source: BSE
In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the audio recording of the Earning Conference Call for the...
03 Feb, 2026 | 05:43pm • Source: BSE
Investor Presentation for the Q3 and 9M ended on December 31, 2025
03 Feb, 2026 | 01:24pm • Source: BSE
Unaudited Financial Results for the Q3 and 9M ended on December 31, 2025
03 Feb, 2026 | 01:22pm • Source: BSE
In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, this is to inform you that the Earnings Conference Call...
29 Jan, 2026 | 04:15pm • Source: BSE
In accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herewith intimate about the allotment of shares under ESOP,...
17 Jan, 2026 | 12:10pm • Source: BSE
In accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herewith intimate about the allotment of shares under AIL...
01 Jan, 2026 | 04:36pm • Source: BSE
Further, with reference to the intimation dated November 6, 2025 submitted vide Ref. No. AIL/SE/47/2025-26, in accordance with Regulation 30 and all other applicable provisions...
21 Nov, 2025 | 12:47pm • Source: NSE
Further, with reference to the intimation dated November 6, 2025 submitted vide Ref. No. AIL/SE/47/2025-26, in accordance with Regulation 30 and all other applicable provisions...
21 Nov, 2025 | 12:32pm • Source: BSE
In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we herewith inform that the Nomination and Remuneration Committee of...
20 Nov, 2025 | 01:08pm • Source: NSE
Further, with reference to the intimation dated November 6, 2025 submitted vide Ref. No. AIL/SE/47/2025-26, in accordance with Regulation 30 and all other applicable provisions...
19 Nov, 2025 | 08:10pm • Source: BSE